Larimar Therapeutics, Inc. (DE:ZA71)
NASDAQ:ZA71
Earnings Data
Report Date
Aug 06, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.34Last Year’s EPS
-0.35Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
DE:ZA71 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:ZA71 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 14, 2026 | €3.48 | €3.44 | -1.15% |
Mar 19, 2026 | €3.84 | €3.66 | -4.69% |
Nov 05, 2025 | €3.26 | €3.24 | -0.61% |
Aug 14, 2025 | €3.20 | €3.12 | -2.50% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Larimar Therapeutics, Inc. (DE:ZA71) report earnings?
Larimar Therapeutics, Inc. (DE:ZA71) is schdueled to report earning on Aug 06, 2026, Before Open (Confirmed).
What is Larimar Therapeutics, Inc. (DE:ZA71) earnings time?
Larimar Therapeutics, Inc. (DE:ZA71) earnings time is at Aug 06, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Larimar Therapeutics, Inc. stock?
The P/E ratio of Larimar Therapeutics is N/A.
What is DE:ZA71 EPS forecast?
DE:ZA71 EPS forecast for the fiscal quarter 2026 (Q2) is -0.34.
